代表研究
Journal of Medical Virology · 2023
COVID-19:Molnupiravir 的療效與安全性
比較住院與非住院 COVID-19 患者的治療證據。
查看論文 (COVID-19:Molnupiravir 的療效與安全性,新分頁)↗
完整題名
Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials.
DOI: 10.1002/jmv.28621
Frontiers in Medicine · 2023
COVID-19:褪黑激素的臨床效果
整合隨機試驗,評估褪黑激素治療 COVID-19 的臨床效果。
查看論文 (COVID-19:褪黑激素的臨床效果,新分頁)↗
完整題名
The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
DOI: 10.3389/fmed.2023.1171294
Intensive and Critical Care Nursing · 2026
敗血症:超短效 β-blocker 與死亡率
整合隨機試驗與試驗序列分析,評估敗血症或敗血性休克患者的治療證據。
查看論文 (敗血症:超短效 β-blocker 與死亡率,新分頁)↗
完整題名
Effect of ultrashort-acting β-blocker on the mortality of patients with sepsis or septic shock: A systematic review and trial sequential meta-analysis of randomized controlled trials
DOI: 10.1016/j.iccn.2025.104265
Google Scholar ↗(新分頁) ORCID 學術紀錄 ↗(新分頁)